LQT Therapeutics nabs $19m in Amplitude-led Series A round

Laval, Quebec-based LQT Therapeutics, a pharmaceutical company focused on developing precision therapies for genetic heart diseases, has secured $19 in a Series A financing.

ByVCJ Staff

10 August 2021•6 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America Healthcare Briefs

LQT Therapeutics nabs $19m in Amplitude-led Series A round

Alexandria Venture Investments

Amplitude Ventures

Fonds de Solidarité FTQ

Lumira Ventures

Sanofi

Related articles